5th October 2016

Institut Curie, a world leading research and clinical cancer centre, chooses Mirada’s technology to achieve greater efficiency in radiotherapy patient care across its sites

Institut Curie, a world leading research and clinical cancer centre chooses Mirada’s technology to achieve greater efficiency in radiotherapy patient care across its sites

Release Date: October 05 2016 Oxford, UK

Mirada Medical is proud and excited about the opportunity to work with the clinicians and physicists at Institut Curie, Paris, France, one of the largest oncology research centers in Europe combined with a state-of-the-art hospital group. Founded in 1909 on a model devised by Marie Curie, twice winner of the Nobel prize, and still at the cutting edge from “fundamental research to innovative treatments”, Institut Curie has 3,300 researchers, physicians, clinicians, technicians and administrative staff who work together to provide care to more than 5,000 patients a year.

Mirada specialises in software that facilitates the use of multi-modality images across the continuum of cancer patient care. This natural collaboration will enable the implementation of cutting edge and complex treatment protocols as well as bring efficiency in treatment planning and delivery, improving clinical confidence and efficacy.

 We have chosen Mirada as a partner to bring efficiency gains across all our sites with their automated contouring solutions, and to support the implementation of complex treatment protocols thanks to their multimodality image fusion platform. The flexibility of their software will facilitate the implementation in the existing clinical workflows of our different sites.” said Farid Goudjil, Deputy Head of Medical Physics of Institut Curie.

 Institut Curie is joining many other famous hospital sites in the world that have selected Mirada’s technology for their robust image fusion, adaptive radiotherapy and molecular imaging solutions. This is testimony to the company’s capabilities to support the next generation of pioneering radiotherapy and nuclear medicine departments.

“We’re proud and excited that such a renowned cancer centre in Europe, Institut Curie, has chosen Mirada image technology to add to their state-of-the-art patient care, and we are looking forward to fruitful collaboration.” said Matthieu Leclerc-Chalvet, Managing Director of Mirada Medical.

About Mirada Medical Ltd

Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada’s products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, Multidisciplinary meetings and elsewhere.

Mirada’s technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada’s world headquarters in Oxford, England. For more information about Mirada Medical products visit https://www.mirada-medical.com

RTx, Workflow Box and Mirada Medical are trademarks of Mirada Medical Ltd.

For more information, please contact Mirada’s Global Headquarters:

Mirada Medical Ltd

Oxford Centre for Innovation

New Road, Oxford

OX1 1BY United Kingdom

Tel: +44(0)1865 261410